CHP
PFE icon

Cable Hill Partners’s Pfizer PFE Stock Holding History

Cable Hill Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$558K Buy
22,847
+1,503
+7% +$39.3K 0.05% 79
2024
Q4 		$566K Buy
21,344
+3,632
+21% +$98.5K 0.06% 78
2024
Q3 		$513K Sell
17,712
-1,819
-9% -$53.1K 0.05% 86
2024
Q2 		$546K Buy
19,531
+4,774
+32% +$131K 0.06% 74
2024
Q1 		$434K Hold
14,757
– – 0.05% 66
2023
Q4 		$434K Sell
14,757
-682
-4% -$20.6K 0.05% 66
2023
Q3 		$512K Buy
15,439
+1,478
+11% +$52.3K 0.07% 66
2023
Q2 		$512K Sell
13,961
-352
-2% -$13.7K 0.07% 68
2023
Q1 		$584K Buy
14,313
+1,723
+14% +$74.4K 0.1% 58
2022
Q4 		$645K Sell
12,590
-1,665
-12% -$79.8K 0.12% 57
2022
Q3 		$624K Buy
14,255
+1,708
+14% +$83K 0.13% 57
2022
Q2 		$658K Sell
12,547
-2,005
-14% -$102K 0.16% 57
2022
Q1 		$753K Buy
14,552
+121
+0.8% +$6.28K 0.49% 33
2021
Q4 		$852K Buy
14,431
+25
+0.2% +$1.24K 0.18% 50
2021
Q3 		$620K Hold
14,406
– – 0.15% 56
2021
Q2 		$564K Buy
14,406
+1,198
+9% +$46.6K 0.13% 56
2021
Q1 		$479K Buy
13,208
+2,137
+19% +$75.9K 0.13% 53
2020
Q4 		$408K Sell
11,071
-598
-5% -$21.9K 0.11% 61
2020
Q3 		$406K Buy
11,669
+20
+0.2% +$701 0.12% 52
2020
Q2 		$361K Buy
11,649
+5
+0% +$170 0.12% 51
2020
Q1 		$361K Sell
11,644
-851
-7% -$29K 0.13% 55
2019
Q4 		$464K Buy
+12,495
New +$445K 0.14% 50
2019
Q3 		– Sell
-6,364
Closed -$262K – 109
2019
Q2 		$262K Buy
6,364
+741
+13% +$29.4K 0.09% 88
2019
Q1 		$227K Buy
5,623
+258
+5% +$10.3K 0.08% 103
2018
Q4 		$222K Sell
5,365
-31
-0.6% -$1.29K 0.09% 94
2018
Q3 		$228K Sell
5,396
-360
-6% -$13.9K 0.09% 59
2018
Q2 		$198K Hold
5,756
– – 0.08% 73
2018
Q1 		$192K Sell
5,756
-668
-10% -$23K 0.08% 77
2017
Q4 		$224K Sell
6,424
-991
-13% -$33.8K 0.1% 77
2017
Q3 		$251K Buy
7,415
+3,927
+113% +$126K 0.12% 69
2017
Q2 		$112K Sell
3,488
-1,428
-29% -$45K 0.06% 82
2017
Q1 		$160K Buy
4,916
+279
+6% +$8.8K 0.08% 66
2016
Q4 		$143K Sell
4,637
-687
-13% -$21K 0.06% 71
2016
Q3 		$170K Buy
5,324
+325
+7% +$10.9K 0.12% 61
2016
Q2 		$170K Sell
4,999
-815
-14% -$26K 0.13% 53
2016
Q1 		$167K Buy
5,814
+1,333
+30% +$38.1K 0.13% 45
2015
Q4 		$138K Sell
4,481
-657
-13% -$20.7K 0.1% 55
2015
Q3 		$156K Sell
5,138
-655
-11% -$21K 0.12% 47
2015
Q2 		$186K Sell
5,793
-316
-5% -$10.3K 0.14% 40
2015
Q1 		$199K Sell
6,109
-1,146
-16% -$36.4K 0.15% 38
2014
Q4 		$214K Buy
+7,255
New +$208K 0.21% 30

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cable Hill Partners's PFE Position: Q1 2025 in Review

Cable Hill Partners increased its Pfizer (PFE) stake by 7% in Q1 2025, buying an estimated $39.3K and bringing the position to 22,847 shares worth $558K. The position accounts for 0.05% of the portfolio, ranked #79.

Cable Hill Partners first reported a position in PFE in Q4 2014 and has held it in 41 quarters since. The position peaked at $852K in Q4 2021. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Cable Hill Partners held 22,847 shares of Pfizer worth $558K as of Q1 2025.
  • Cable Hill Partners bought 1,503 Pfizer shares in Q1 2025, an estimated $39.3K.
  • Pfizer made up 0.05% of Cable Hill Partners's portfolio in Q1 2025, its #79 holding.
  • Cable Hill Partners first reported a position in Pfizer in Q4 2014 and has held it in 41 quarters since.
  • Cable Hill Partners's Pfizer position peaked at $852K in Q4 2021.
  • 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Cable Hill Partners's 13F filing for Q1 2025, filed 2 May 2025.